Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Acquisitions (2024 - 2025)

Mimedx (MDXG) has disclosed Acquisitions for 4 consecutive years, with $3.1 million as the latest value for Q3 2025.

  • Quarterly Acquisitions changed N/A to $3.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, down 52.12% year-over-year, with the annual reading at $3.8 million for FY2025, 52.12% down from the prior year.
  • Acquisitions hit $3.1 million in Q3 2025 for Mimedx, up from $700000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $5.0 million in Q1 2024 to a low of $366000.0 in Q2 2024.